Facebook
Twitter
LinkedIn
ForwardASBMT Clinical Research Training Course 2016
The ASBMT Board of Directors created the course in 2006 because of concerns that clinical fellowship programs don’t adequately cover the principles of research and how to take findings from the laboratory to the clinic. The course helps close the gap by addressing those deficiencies. The course includes formal presentations and extensive follow-up dialogue and small-group discussion, covering topics such as:
- Research subject eligibility and recruitment
- Clinical trial design
- Biostatistics
- Data management and quality control
- Study endpoints
- Late effects and quality of life
- Clinical pharmacology, including polypharmacy and drug interactions
- Regulatory compliance
- Relationships with pharmaceutical companies and third-party payers
- Opportunities for grants and clinical research training
- Grant writing
- Working with a mentor
- Translational trials
- Working with laboratory investigators
- Research ethics
- Subject safety
Each participant will be expected to have a research project that can be developed in discussions with faculty and with peers.
This educational activity is being supported by:
Target Audience
Physicians and allied health professionals
Learning Objectives
At the conclusion of this activity, scholars should be able to:
- Provide Scholars with an opportunity to present their research to their peers and BMT Faculty
- Provide Scholars with critical input regarding clinical trial design and implementation.
- Prepare Scholars for presenting their research at national meetings
- Foster mentoring and networking between faculty and scholars in an intimate environment
- Reinforce participants’ commitment to the stem cell transplantation community
Planning Committee:
Christopher N. Bredeson, MD, MSc
Catherine Bollard, MD
Daniel Couriel, MD
Corey Cutler, MD
Marcos De Lima, MD
Steven Devine, MD
Ronald Gress
Margaret MacMillan, MD
Joycelynn Palmer
Brenda Sandmaier, MD
Ted Gooley, PhD
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following and in accordance with the ACCME® standards for Commercial Support Number 6, these relationships were reviewed via the MCW conflict of interest resolution process and resolved.
| Name | Company | Role |
| Corey Cutler, MD | Novartis | Advisory Board |
| Seattle Genetics | Advisory Board | |
| Pfizer | Advisory Board | |
| Kite Pharmaceutical | Advisory Board | |
| Insys | Advisory Board | |
| Reg Immune | Advisory Board | |
| Incyte | Advisory Board | |
| Christopher Bredeson, MD, MSC, FRCPC | Sanofi | Speaker |
| Otsuka | Speaker | |
| Seattle Genetics | Speaker | |
| Margaret MacMillan, MD | Seattle Genetics | Advisory |
| Baxalta Immunology | Advisory | |
| Marcos de Lima, MD | Novartis | Consultant |
| Brenda Sandmaier, MD | EpiThany, Blaze | (Spouse) consultantant |
| Gilead | (Spouse) Scientist | |
| ArevaMed | Advisory Board/Consultant | |
| Daniel Couriel, MD | Merck, Inc | Advisory Board/Speaker |
Available Credit
- 38.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 38.00 Hours of ParticipationHours of Participation credit.